There are 2867 resources available
Conclusions and perspectives
Presenter: Adil Daud
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Webcast
279O - ctDNA detection in cerebrospinal fluid and concordance with the primary tumor in a multicenter prospective study of patients with glioma
Presenter: Santiago Cabezas-Camarero
Session: Proffered Paper session: CNS tumours
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: The impact of COVID-19 on patients with cancer: Lessons learnt and pathway for the future
Resources:
Webcast
Conclusions and perspectives
Presenter: Violeta Serra
Session: Exploiting synthetic lethality: The next generation
Resources:
Webcast
Discussion
Presenter: All Speakers
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Webcast
Conclusions and perspectives
Presenter: Andrea Sartore Bianchi
Session: Are novel immunotherapeutics and targeted treatments going to transform the management of CRC?
Resources:
Slides
Webcast
LBA30 - Phase III ATALANTE/ov29 trial: Atezolizumab (Atz) versus placebo with platinum-based chemotherapy (Cx) plus bevacizumab (bev) in patients (pts) with platinum-sensitive relapse (PSR) of epithelial ovarian cancer (OC)
Presenter: Jean Emmanuel Kurtz
Session: Proffered Paper session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
280O - Pharmacokinetics and pharmacodynamics of paxalisib in newly diagnosed glioblastoma patients with unmethylated MGMT promoter status: Final phase II study results
Presenter: John de Groot
Session: Proffered Paper session: CNS tumours
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Exploiting synthetic lethality: The next generation
Resources:
Webcast
Invited Discussant 279O and 280O
Presenter: Filip De Vos
Session: Proffered Paper session: CNS tumours
Resources:
Webcast